Susan E. Burwig - 26 Oct 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Oct 2026, 16:23:06 UTC
Prior SEC filing
23 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Susan E. Burwig
Filing notes and source

Key filing fact

Susan E. Burwig filed Form 4 for Medpace Holdings, Inc. (MEDP) on 28 Oct 2026.

Key facts

  • This page summarizes Susan E. Burwig's Form 4 filing for Medpace Holdings, Inc. (MEDP).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 28 Oct 2026, 16:23.

Change

  • Previous filing in this sequence was filed on 23 Oct 2026.
  • Current net transaction value: -$13,540,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001677418 Primary reporting owner

BURWIG SUSAN E

Relationship
Exec. VP, Operations
Address
C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Susan E. Burwig
Signature date
28 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP transaction

Common Stock

Sale

Transaction value
-$10,872,620
Shares
-16,060
Change %
-22%
Price
$677.00
Shares after
57,624
Date
26 Oct 2026
Ownership
Direct
Footnotes
F1
MEDP transaction

Common Stock

Options Exercise

Transaction value
Shares
+328
Change %
+0.57%
Price
$166.73*
Shares after
57,952
Date
26 Oct 2026
Ownership
Direct
MEDP transaction

Common Stock

Sale

Transaction value
-$2,667,380
Shares
-3,940
Change %
-6.8%
Price
$677.00
Shares after
54,012
Date
27 Oct 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEDP transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-328
Change %
-100%
Price
$0.000000*
Shares after
0
Date
26 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
328
Exercise price
$166.73
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

Footnote F2

The option vested in full on October 27, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .